Page 26 of 35

DR10.10 | Vaginal Discharge Syndromic Management — SDL Guide (Part 2)

Interpreting Microscopy and Clinical Findings

A four-panel medical diagram compares clue cells, Trichomonas vaginalis, Candida pseudohyphae with budding yeast, and strawberry cervix, with a bottom strip integrating pH, whiff test, discharge, and microscopy for diagnosis. — **Panel A:** Saline wet mount showing clue cell, squamous epithelial cell, adherent coccobacilli, stippled indistinct cell borders, bacterial vaginosis.. **Panel B:** Saline wet mount showing Trichomonas vaginalis, pear-shaped flagellate, anterior flagella, nucleus, undulating membrane, trichomoniasis.. **Panel C:** KOH mount showing Candida pseudohyphae, budding yeast cells, vulvovaginal candidiasis.. **Panel D:** Clinical cervix showing strawberry cervix, punctate hemorrhages, colpitis macularis, trichomoniasis clue.. **Bottom strip:** Diagnostic integration pathway showing discharge character, vaginal pH, whiff test, microscopy, treatment branch, and cervicitis warning for excess neutrophils without visible pathogen..

Interpreting the bedside findings pulls the diagnosis together and confirms which treatment branch to follow. On the saline wet mount, clue cells (vaginal epithelial cells studded with coccobacilli so that their borders look stippled and indistinct) point to bacterial vaginosis, while motile pear-shaped flagellates confirm trichomoniasis; an excess of neutrophils without a clear pathogen should raise suspicion of cervicitis. On the KOH mount, pseudohyphae with budding yeast confirm vulvovaginal candidiasis. The strawberry cervix (colpitis macularis — punctate haemorrhages on the cervix) is pathognomonic of trichomoniasis but is seen clinically in only a small minority of cases, so its absence does not exclude the diagnosis. Where microscopy is unavailable, you treat syndromically on the clinical pattern. Always integrate the discharge character, pH, and whiff result with the microscopy rather than relying on any single finding.

Three-panel microscopy comparison showing clue cells in bacterial vaginosis, motile Trichomonas vaginalis, and Candida pseudohyphae with budding yeast. — **Panel A:** Wet prep showing clue cells: squamous epithelial cells with stippled edges from adherent bacteria, diagnostic of bacterial vaginosis.. **Panel B:** Wet prep showing Trichomonas vaginalis: pear-shaped motile flagellate with flagella and undulating membrane, diagnostic of trichomoniasis.. **Panel C:** KOH mount showing Candida: pseudohyphae and budding yeast cells, diagnostic of vulvovaginal candidiasis.. **Bottom strip:** Interpretation pointers linking clue cells, motile flagellates, and pseudohyphae with their syndromic diagnoses, plus syndromic treatment when microscopy is unavailable..

Interpretation pointers:
- Clue cells on wet mount → bacterial vaginosis
- Motile flagellates on wet mount → trichomoniasis (strawberry cervix, when present, is pathognomonic)
- Pseudohyphae + budding yeast on KOH → vulvovaginal candidiasis
- No microscopy available → treat syndromically on the clinical pattern

SELF-CHECK

During risk stratification of a woman with vaginal discharge, you find her partner has urethral discharge and she has mucopurulent cervical discharge. What does NACO syndromic management direct you to do?

A. Treat for vaginal discharge alone (Kit 2), since the discharge is vaginal

B. Treat for vaginal discharge AND add cervicitis cover (Kit 1) because cervicitis risk factors are present

C. Give an antifungal only and review in one month

D. Withhold all treatment until culture results return

Reveal Answer

Answer: B. Treat for vaginal discharge AND add cervicitis cover (Kit 1) because cervicitis risk factors are present

When cervicitis risk factors are present (e.g. a partner with urethral discharge, mucopurulent cervical discharge, multiple partners), NACO directs you to add cervicitis cover (Kit 1, for gonorrhoea/chlamydia) to the vaginal-discharge treatment (Kit 2). Treating the vaginal discharge alone would leave a cervicitis to ascend toward pelvic inflammatory disease.

Syndromic Management With NACO Kit 2 and Partner Counselling

comparison table: three vaginal discharge causes — BV vs VVC vs Trichomoniasis — columns: organism, discharge characteristics (colour/consistency/odour), pH, microscopy finding, NACO treatment, partner treatment (yes/no), pregnancy considerations — click to enlarge

Applied management of vaginal discharge under NACO uses Kit 2 (green) — per current NACO guidance, exact drugs to be confirmed against the latest protocol — and the key skill is matching treatment and partner-management to the cause. Metronidazole covers both bacterial vaginosis and trichomoniasis, while clotrimazole (or fluconazole) covers the candidiasis component. The partner-treatment rule is critical and often confused: trichomoniasis requires treatment of the sexual partner (it is sexually transmitted and partners reinfect each other), whereas bacterial vaginosis does NOT routinely require partner treatment (the evidence shows no benefit). Counsel every patient to complete the course, abstain from sex during treatment, and — importantly with metronidazole — avoid alcohol because of a disulfiram-like reaction. Offer HIV testing, arrange follow-up at about 7 days, and address pregnancy considerations (BV and candidiasis are treated in pregnancy with appropriate agents). Treatment failure or recurrence prompts reassessment, including for a missed cervicitis.

A colour-coded comparison table summarizes bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis by organism, discharge, pH, microscopy, treatment, partner treatment, and pregnancy considerations. — **Panel A:** Comparison table showing organism, discharge characteristics, vaginal pH, microscopy finding, NACO Kit 2 coverage, partner treatment, and pregnancy considerations for BV, VVC, and trichomoniasis.. **Panel B:** Management essentials: complete course, abstain during treatment, avoid alcohol with metronidazole, offer HIV testing, follow up around 7 days, reassess failure for cervicitis.. **Panel C:** Partner treatment pearl highlighting that trichomoniasis requires partner treatment, while bacterial vaginosis does not routinely require partner treatment..

Management essentials:
- NACO Kit 2 (green): metronidazole (covers BV + trichomoniasis) + clotrimazole/fluconazole (candidiasis)
- Partner treatment: YES for trichomoniasis; NOT routine for bacterial vaginosis
- Counsel: complete course, abstain during treatment, avoid alcohol with metronidazole
- Offer HIV testing, follow up ~7 days, manage pregnancy appropriately; reassess failure for cervicitis

SELF-CHECK

Which statement about partner treatment in vaginal discharge syndromes is correct?

A. Partner treatment is required for bacterial vaginosis but not for trichomoniasis

B. Partner treatment is required for trichomoniasis but is NOT routinely recommended for bacterial vaginosis

C. Partner treatment is required for all three causes equally

D. Partner treatment is never needed for any vaginal discharge syndrome

Reveal Answer

Answer: B. Partner treatment is required for trichomoniasis but is NOT routinely recommended for bacterial vaginosis

Trichomoniasis is sexually transmitted and requires treatment of the partner to prevent reinfection. Bacterial vaginosis is a dysbiosis rather than a classically transmitted infection, and partner treatment is NOT routinely recommended because evidence shows no benefit. This distinction is a frequent point of confusion and is clinically important.

Self-Assessment: Vaginal Discharge Syndromic Management

Infographic comparing bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis by discharge, pH, microscopy, treatment, partner management, and NACO cervicitis-cover decision. — **Panel A:** Clinical approach flowchart with patient presentation, history and examination, discharge assessment, pH, whiff test, microscopy, and NACO risk stratification.. **Panel B:** Side-by-side comparison of bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis showing discharge appearance, pH, microscopy, drug choice, and partner-treatment rule.. **Panel C:** Microscopy fields showing clue cells, budding yeast with pseudohyphae on KOH mount, and motile Trichomonas vaginalis.. **Panel D:** NACO risk-stratification decision pathway showing when to add Kit 1 cervicitis cover.. **Panel E:** Clinical pearl and counseling reminders: fishy grey discharge indicates BV, partner treatment rules, and alcohol avoidance with metronidazole..

Consolidate your command of this syndrome before moving on, because vaginal discharge is the presentation where similar-looking conditions demand genuinely different actions, and where a confident clinician saves a patient repeated, futile clinic visits. Work through the self-check below as if a woman were in front of you, naming the cause, the pH, the microscopy finding, the kit, and — every time — the partner-treatment rule, since that is the single point learners most often get wrong. Give special attention to two ideas: that a fishy grey discharge is bacterial vaginosis and not candidiasis, and that the NACO risk-stratification step decides whether you must add cervicitis cover. Where any answer feels uncertain, return to the relevant section and rehearse the distinction until it is automatic, because in a busy clinic you default to whatever you have practised. Treat each gap as a prompt for revision, not a reason for doubt.

Self-check questions:
- What are the four Amsel criteria, and how many are needed to diagnose BV?
- What does the KOH mount show in vulvovaginal candidiasis?
- Which drug covers both BV and trichomoniasis, and which covers candidiasis?
- For which cause(s) must you treat the partner, and for which not?
- When does NACO direct you to add cervicitis cover (Kit 1)?
- Why must patients avoid alcohol while taking metronidazole?

CLINICAL PEARL

The fishiest pitfall in vaginal discharge is mislabelling bacterial vaginosis as 'a fungal infection' and prescribing an antifungal — a grey, fishy, pH-elevated discharge with clue cells is BV, and it needs metronidazole, not clotrimazole. Two reflexes will keep you safe: pair every metronidazole prescription with a clear 'no alcohol' warning to avoid the disulfiram-like reaction, and remember the partner rule as a single phrase — 'treat the partner for trichomoniasis, not for BV'. And never let a 'simple discharge' distract you from the cervicitis risk-stratification step that protects future fertility.